News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY
Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 -
-
-
-